{"database": "lobbying", "table": "lobbying_activities", "rows": [[1988114, "3256e429-ce0d-4246-9b64-204ca197d884", "Q2", "ROCK & ASSOCIATES", 33545, "DIAMONDBACK DRUGS", 2017, "second_quarter", "LAW", "Controlled substance issues pertaining to pharmacy compounding.  H.R. 2871, Patient Access to Compounded Medications Act of 2017.", "HOUSE OF REPRESENTATIVES,SENATE", 11250, null, 0, 0, "2017-07-15T11:07:38.350000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1988114"], "units": {}, "query_ms": 5.188039969652891, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}